← Leaderboards
Kelly A Birdwell
Vanderbilt University
$3,186,569
Attributed
$3,186,569
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $354.7K · FY2007–25$500K$375K$250K$125K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,186,569 · 4
By mechanism
U01$2,188,814 · 1
K23$942,300 · 1
M01$55,455 · 2
Top collaborators
No co-investigators on record.
Most similar at Vanderbilt University
Same institution · by research overlap
- John Atlas Phillips III$14,651,319
- Rizwan Hamid$10,654,735
- John Hughes Newman$11,268,781
- Digna R Velez Edwards$11,329,288
- Joshua C. Denny$39,465,922
Others in their field
Top investigators on “United States National Institutes Of Health”
- Leonard Freedman · Leidos Biomedical Research, Inc.$816,847,401
- Sonia M Thomas · Research Triangle Institute$701,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$642,073,624
- Bambra Strokes · Ppd Development Lp$526,656,217
- Lawrence Corey · Fred Hutchinson Cancer Center$513,687,120
- Tracy L Nolen · Research Triangle Institute$474,487,152
Research focus
United States National Institutes Of HealthKidney TransplantationGenesEnd Stage Renal FailureGenotypeChronicGeneticVariantCohortKidney DiseasesHypertensionQuality Of LifeTransplantationResponseResourcesFundingDna DatabasesDialysis ProcedurePharmacogenomicsUnited StatesComputerized Medical RecordEnvironmentBaseGenetic Variant
Grant awards (17)
Long-term Kidney Transplantation Outcomes Network (APOLLO) Clinical Center$217,380
U01 · FY2025 · DK · contact PI
Long-term Kidney Transplantation Outcomes Network (APOLLO) Clinical Center$215,000
U01 · FY2024 · DK · contact PI
Long-term Kidney Transplantation Outcomes Network (APOLLO) Clinical Center$333,017
U01 · FY2023 · DK · contact PI
APOL1 and Kidney Transplantation Outcomes Vanderbilt Clinical Center$306,448
U01 · FY2022 · DK · contact PI
APOL1 and Kidney Transplantation Outcomes Vanderbilt Clinical Center$133,332
U01 · FY2020 · DK · contact PI
APOL1 and Kidney Transplantation Outcomes Vanderbilt Clinical Center$346,140
U01 · FY2019 · DK · contact PI
APOL1 and Kidney Transplantation Outcomes Vanderbilt Clinical Center$269,850
U01 · FY2018 · DK · contact PI
APOL1 and Kidney Transplantation Outcomes Vanderbilt Clinical Center$84,825
U01 · FY2018 · DK · contact PI
APOL1 and Kidney Transplantation Outcomes Vanderbilt Clinical Center$282,822
U01 · FY2017 · DK · contact PI
Pharmacogenomics of Tacrolimus and New Onset Diabetes After Kidney Transplant$124,114
K23 · FY2015 · GM · contact PI
Pharmacogenomics of Tacrolimus and New Onset Diabetes After Kidney Transplant$64,346
K23 · FY2015 · GM · contact PI
Pharmacogenomics of Tacrolimus and New Onset Diabetes After Kidney Transplant$188,460
K23 · FY2014 · GM · contact PI
Pharmacogenomics of Tacrolimus and New Onset Diabetes After Kidney Transplant$188,460
K23 · FY2013 · GM · contact PI
Pharmacogenomics of Tacrolimus and New Onset Diabetes After Kidney Transplant$188,460
K23 · FY2012 · GM · contact PI
Pharmacogenomics of Tacrolimus and New Onset Diabetes After Kidney Transplant$188,460
K23 · FY2011 · GM · contact PI
INFLUENZA AND RENAL TRANSPLANT RECIPIENTS$2,495
M01 · FY2008 · RR · contact PI
INFLUENZA AND RENAL TRANSPLANT RECIPIENTS$52,960
M01 · FY2007 · RR · contact PI